相似文献
1
Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination.
Ann Allergy Asthma Immunol. 2021 Aug;127(2):257-258. doi: 10.1016/j.anai.2021.04.024. Epub 2021 May 5.
2
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
Ann Allergy Asthma Immunol. 2021 Apr;126(4):319-320. doi: 10.1016/j.anai.2021.01.017. Epub 2021 Jan 23.
3
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19.
4
Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):193-195. doi: 10.18176/jiaci.0680. Epub 2021 Feb 12.
5
Mounting evidence suggests Sputnik COVID vaccine is safe and effective.
Nature. 2021 Jul;595(7867):339-340. doi: 10.1038/d41586-021-01813-2.
6
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
N Engl J Med. 2021 Apr 8;384(14):1372-1374. doi: 10.1056/NEJMc2101667. Epub 2021 Mar 10.
7
Specialist allergy advice allows vaccination in patients with reactions to COVID-19 vaccines.
Clin Exp Allergy. 2022 Mar;52(3):465-469. doi: 10.1111/cea.14069. Epub 2021 Dec 6.
8
Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2.
JAMA Ophthalmol. 2021 Jul 1;139(7):e212471. doi: 10.1001/jamaophthalmol.2021.2471. Epub 2021 Jul 21.
9
Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020.
Am J Transplant. 2021 Mar;21(3):1332-1337. doi: 10.1111/ajt.16516.
10
Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2.
引用本文的文献
1
A Nationwide Survey of mRNA COVID-19 Vaccinee's Experiences on Adverse Events and Its Associated Factors.
J Korean Med Sci. 2023 Jun 5;38(22):e170. doi: 10.3346/jkms.2023.38.e170.
2
Clinical Effects of BNT162b2 Vaccine on the Short-Term Course of Chronic Spontaneous Urticaria Patients.
Indian J Dermatol. 2022 Nov-Dec;67(6):674-681. doi: 10.4103/ijd.ijd_543_22.
3
Risk of Adverse Events of Live-Attenuated COVID-19 Vaccination Among Atopic Patients.
J Asthma Allergy. 2022 Nov 10;15:1605-1621. doi: 10.2147/JAA.S386611. eCollection 2022.
4
Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review.
Medicines (Basel). 2022 Aug 11;9(8):43. doi: 10.3390/medicines9080043.
5
The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety: A Pilot Study on a "Hub-and-Spoke" Model for Population-Wide Allergy Service.
Ann Allergy Asthma Immunol. 2022 Sep;129(3):308-312.e1. doi: 10.1016/j.anai.2022.05.011. Epub 2022 May 20.
6
Evaluation of the Autoimmunity and Preexisting Risky Conditions for Hypersensitivity Reactions to COVID-19 Vaccines.
Int Arch Allergy Immunol. 2022;183(6):651-661. doi: 10.1159/000521709. Epub 2022 Feb 3.
7
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2.
Allergy Asthma Proc. 2022 Jan 1;43(1):30-36. doi: 10.2500/aap.2022.43.210111.
8
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases.
Vaccines (Basel). 2021 Oct 8;9(10):1147. doi: 10.3390/vaccines9101147.
9
Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis.
Allergy Asthma Clin Immunol. 2021 Oct 16;17(1):109. doi: 10.1186/s13223-021-00613-7.
Zotero 插件